Mantosh Kumar Satapathy | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Dr. Mantosh Kumar Satapathy | Pharmacology | Best Researcher Award

Mantosh Kumar Satapathy  | Taipei Medical University | Taiwan

Dr. Mantosh Kumar Satapathy, Ph.D., is a distinguished biomedical scientist, biotechnologist, pharmacologist, and tissue engineer based at Taipei Medical University, Taiwan, with extensive international experience in pharmacology, biomedical engineering, and nanobiotechnology. He earned his Ph.D. in Biomedical Materials and Tissue Engineering from Taipei Medical University, following an M.Tech. in Industrial Biotechnology and a Bachelor of Pharmacy, establishing a strong foundation in translational medical research. Dr. Satapathy has held postdoctoral and research fellow positions at leading institutions, leading projects on advanced nanodrug delivery systems, stem cell therapeutics, tissue engineering, and nanoformulation design, while supervising molecular biology laboratories and mentoring junior researchers. His research contributions include the development of stimuli-responsive nanocomposite hydrogels for orthopedic and skin tissue regeneration, engineering of nanocurcumin-based formulations for targeted therapies, and investigations into gene regulation and drug repurposing in cancer and skin pathologies. He has published extensively in high-impact peer-reviewed journals, contributed to international book chapters, co-invented a U.S. patent, and presented his work at global scientific conferences. Dr. Satapathy’s work has been recognized with multiple Outstanding Postdoctoral Researcher awards, and he actively serves as a peer reviewer, reflecting his leadership in the scientific community. He is a life member of professional organizations, has completed specialized research training in molecular diagnostics and biotechnology, and continues to advance interdisciplinary research that bridges fundamental science and clinical application, demonstrating exceptional impact in biomedical innovation.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Banerjee, P., Satapathy, M., Mukhopahayay, A., & Das, P. (2014). Leaf extract mediated green synthesis of silver nanoparticles from widely available Indian plants: Synthesis, characterization, antimicrobial property and toxicity analysis. Bioresources and Bioprocessing, 1(1), 3.

2. Satapathy, M. K., Yen, T. L., Jan, J. S., Tang, R. D., Wang, J. Y., Taliyan, R., & Yang, C. H. (2021). Solid lipid nanoparticles (SLNs): An advanced drug delivery system targeting brain through BBB. Pharmaceutics, 13(8), 1183.

3. Satapathy, M. K., & Das, P. (2014). Optimization of crystal violet dye removal using novel soil-silver nanocomposite as nanoadsorbent using response surface methodology. Journal of Environmental Chemical Engineering, 2(1), 708–714.

4. Satapathy, M. K., Banerjee, P., & Das, P. (2015). Plant-mediated synthesis of silver-nanocomposite as novel effective azo dye adsorbent. Applied Nanoscience, 5(1), 1–9.

5. Satapathy, M. K., Nyambat, B., Chiang, C. W., Chen, C. H., Wong, P. C., Ho, P. H., … (2018). A gelatin hydrogel-containing nano-organic PEI–Ppy with a photothermal responsive effect for tissue engineering applications. Molecules, 23(6), 1256.

Laura Machin Galarza | Pharmacology | Young Scientist Award

Published on by World Top Scientists

Assist. Prof. Dr. Laura Machin Galarza | Pharmacology | Young Scientist Award

Laura Machin Galarza | University of Havana | Cuba

Dr. Laura Machin Galarza is an Assistant Professor and Researcher at the Institute of Pharmacy and Foods, University of Havana, specializing in pharmaceutical sciences and parasitology. She holds a Bachelor’s, Master’s, and Doctorate in Pharmaceutical Sciences from the University of Havana, where her academic journey has been marked by excellence and commitment to translational research. Dr. Machin has undertaken prestigious research stays at institutions in Austria, Germany, China, and Cuba, contributing to international collaborations focused on pharmacology, toxicology, and biopharmaceutical innovation. Her professional experience includes leadership in multidisciplinary projects exploring the antiprotozoal and antileishmanial potential of natural and synthetic compounds, advanced drug delivery systems, and pharmacological recycling strategies. She has authored multiple peer-reviewed publications in high-impact journals such as Pharmaceuticals, Molecules, and Experimental Parasitology, demonstrating expertise in medicinal chemistry and drug development. Dr. Machin’s work has been recognized through contributions to award-winning research honored by the Cuban Academy of Sciences. She actively serves in academic editorial processes, participates in professional scientific societies, and holds certifications that reflect her dedication to research excellence, innovation, and scientific leadership in the field of pharmaceutical sciences.

Profiles: Google Scholar | Scopus 

Featured Publications

1. B. Salehi, L. Machin, L. Monzote, J. Sharifi-Rad, S. M. Ezzat, M. A. Salem, et al., “Therapeutic potential of quercetin: new insights and perspectives for human health,” ACS Omega, vol. 5, no. 20, pp. 11849–11872, 2020.

2. B. Tamargo, L. Monzote, A. Piñón, L. Machín, M. García, R. Scull, W. N. Setzer, “In vitro and in vivo evaluation of essential oil from Artemisia absinthium L. formulated in nanocochleates against cutaneous leishmaniasis,” Medicines, vol. 4, no. 2, p. 38, 2017.

3. L. Machín, R. Nápoles, L. Gille, L. Monzote, “Leishmania amazonensis response to artemisinin and derivatives,” Parasitology International, vol. 80, p. 102218, 2021.

4. G. Geroldinger, M. Tonner, J. Quirgst, M. Walter, S. De Sarkar, L. Machín, et al., “Activation of artemisinin and heme degradation in Leishmania tarentolae promastigotes: a possible link,” Biochemical Pharmacology, vol. 173, p. 113737, 2020.

5. L. Machín, B. Tamargo, A. Piñón, R. C. Atíes, R. Scull, W. N. Setzer, L. Monzote, “Bixa orellana L. (Bixaceae) and Dysphania ambrosioides (L.) Mosyakin & Clemants (Amaranthaceae) essential oils formulated in nanocochleates against Leishmania amazonensis,” Molecules, vol. 24, no. 23, p. 4222, 2019.

Zaid Khan | Clinical Pharmacist | Young Researcher Award

Published on by World Top Scientists

Dr. Zaid Khan | Clinical Pharmacist | Young Researcher Award

Zaid Khan | Aditya Bangalore Institute of Pharmacy Education and Research | India

Dr. Zaid Khan is a dedicated and emerging researcher in pharmaceutical sciences with a Doctor of Pharmacy background. He has gained valuable clinical and research experience through internships in reputed hospitals and research institutions, where he contributed to projects involving antibiotic prophylaxis, medication therapy management, and pain management. His work demonstrates strong analytical, clinical, and research design skills, complemented by effective communication and patient counseling abilities. Dr. Khan has published and presented research at national and international platforms and actively engages in professional development through workshops and conferences. His achievements, including recognition as a Young Researcher Award recipient, reflect his commitment to advancing clinical pharmacy and drug safety practices. With a strong interest in bridging research and clinical application, Dr. Khan aspires to contribute to innovative therapeutic strategies, pharmacovigilance, and evidence-based healthcare, positioning himself as a promising professional in the evolving field of pharmaceutical research.

Profiles: Google Scholar | ORCID

Featured Publications

1. Khan, Z., Krishna, D., Daga, S., Rastogih, N., Rekha, M., & Patel, K. (2023). Advancements in minimally invasive surgery: A comprehensive analysis of robotic surgery, endoscopic techniques, and natural orifice translumenal endoscopic surgery. Georgian Medical News, 87–92.

2. Khan, Z., Rekha, M. M., Hiremath, S. R. R., & Shapur, S. R. (2025). A comprehensive study on antibiotic prophylaxis practices across diverse surgical modalities. Journal of Pharmaceutical Care, 93–100.

3. Khan, Z., Ramya, C. V., PR, D. S., & Vishwanath, B. A. (2025). Development and computational analysis of polyherbal chewable lozenges for effective management of mouth and throat infections. Palestinian Medical and Pharmaceutical Journal.

4. Khan, Z. (2024). A case report of advanced periampullary carcinoma: Palliative chemotherapy following Whipple’s surgery. Research & Reviews: Journal of Oncology and Hematology, 13.

5. Zaid, K., & Khan, Z. (2023). Beyond chemotherapy: The promise of immunotherapy in cancer care and advancements in cancer therapy. Research & Reviews: A Journal of Immunology, 13(2), 22–37.

Lixin Yan | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Mrs. Lixin Yan | Pharmacology | Best Researcher Award

Medical manager | Sinocelltech Ltd | China

Mrs. Lixin Yan is an accomplished medical manager with extensive experience in clinical research, specializing in oncology, infectious diseases, vaccines, and metabolic products. Over the years, she has led multiple Phase I–III clinical trials, contributing to protocol development, medical monitoring, feasibility assessment, and regulatory submissions. Her work has been instrumental in the clinical development of innovative therapies, including PD-1 inhibitors, EGFR-targeted treatments, HPV and COVID-19 vaccines, insulin, and GLP-1 products. She demonstrates strong expertise in GCP compliance, regulatory processes, and cross-functional team collaboration, ensuring high-quality research outcomes. Mrs. Yan has published impactful peer-reviewed articles, including first-author papers, highlighting her ability to generate reliable clinical evidence. Her dedication to advancing medical science through rigorous research and mentorship reflects her potential to lead future high-impact studies. Her measurable research impact is demonstrated through 68 citations, 5 documents, and an h-index of 4 according to Scopus.

Profile: Scopus

Featured Publications

1. L. Yan, J. Yi, D. Liu, J. Li, A. A. H. Baidoo, and L. Xie, “Efficacy and safety of SARS-CoV-2 neutralizing antibody, SCTA01, in high-risk outpatients diagnosed with COVID-19: A Phase II clinical trial,” Contemporary Clinical Trials Communications, 2025.

Ksenia Blinova | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Dr. Ksenia Blinova | Pharmacology | Best Researcher Award

Associate Director at US Food and Drug Administration, United States

Dr. Ksenia Blinova, Ph.D., is the Associate Director for the Division of Applied Regulatory Science at the U.S. Food and Drug Administration, where she leads innovative research, regulatory reviews, and scientific consultations that advance translational science in support of public health. With a strong academic foundation in physics, mathematics, and cardiac electrophysiology, she has built a distinguished career focused on bridging fundamental science with regulatory applications. Since joining the FDA as a Commissioner’s Fellow, Dr. Blinova has held key leadership roles, including Deputy Director of the Division of Biomedical Physics, where she led multidisciplinary teams in developing over forty regulatory science tools that improved the evaluation of medical devices across fields such as cardiology, neurostimulation, diagnostics, and patient monitoring. Her career reflects a unique combination of scientific excellence, leadership, and commitment to advancing safe and effective medical products, making her an influential figure in the field of regulatory science.

Professional Profile 

Scopus Profile | ORCID Profile 

Education

Dr. Ksenia Blinova earned her undergraduate and doctoral degrees in Physics and Mathematics from Moscow State University, where she developed a strong foundation in quantitative sciences and analytical problem-solving. She further advanced her academic journey through a postdoctoral fellowship at the National Heart, Lung, and Blood Institute at the National Institutes of Health. Her research during this period centered on cardiac electrophysiology and metabolism, areas that deepened her expertise in biomedical applications of physical sciences. This educational trajectory not only equipped her with advanced technical knowledge but also gave her a unique interdisciplinary perspective that integrates rigorous physics and mathematical methodologies with life sciences and clinical research. Her educational background has been pivotal in shaping her ability to address complex regulatory and scientific challenges, contributing to her capacity for innovation and leadership in translational science and regulatory policy at the intersection of medicine, technology, and public health.

Experience

Dr. Blinova has built a distinguished career at the U.S. Food and Drug Administration, beginning as a Commissioner’s Fellow and progressing to influential leadership roles. As Deputy Director of the Division of Biomedical Physics in the Center for Devices and Radiological Health, she guided a multidisciplinary team in creating innovative regulatory science tools that addressed critical challenges in medical device safety and effectiveness. Her leadership was instrumental in developing methods and resources for fields such as cardiology, neurostimulation, ophthalmology, in-vivo diagnostics, and advanced patient monitoring. Currently serving as Associate Director for the Division of Applied Regulatory Science in the Office of Clinical Pharmacology, she oversees research, scientific consultations, and regulatory reviews that support the FDA’s translational science priorities. Through these roles, she has combined her technical expertise with strategic vision, ensuring that scientific advancements translate into practical regulatory applications that safeguard patient health and promote medical innovation.

Research Focus

Dr. Blinova’s research focuses on advancing translational and regulatory science to accelerate the safe and effective delivery of medical products to patients. Her early work in cardiac electrophysiology and metabolism provided insights into fundamental mechanisms of heart function, laying the groundwork for her later contributions in biomedical physics and device evaluation. At the FDA, she has led research efforts that integrate computational modeling, experimental studies, and regulatory tool development to address complex safety and efficacy challenges in medical devices and drug-device combinations. Her team has developed innovative approaches to evaluate technologies in cardiology, neurostimulation, electrical safety, diagnostics, and patient monitoring, ensuring that regulatory science keeps pace with rapid technological advances. By bridging basic science, applied research, and policy, her work exemplifies the role of regulatory science in translating innovation into tangible benefits for patients and healthcare systems, while maintaining a focus on safety, effectiveness, and public health impact.

Award and Honor

Throughout her career, Dr. Blinova has been recognized for her leadership, innovation, and contributions to regulatory science. Her accomplishments include guiding the development of over forty regulatory tools that have had a lasting impact on how medical devices are assessed for safety and effectiveness. These achievements reflect not only her scientific expertise but also her ability to collaborate across disciplines to solve pressing healthcare challenges. Her recognition within the FDA and broader scientific community underscores her role as a leader who consistently advances the field of translational science. Honors and awards in her career highlight her success in bridging science and regulation, her dedication to patient safety, and her influence in shaping modern approaches to medical product evaluation. These distinctions serve as a testament to her sustained contributions, her commitment to innovation, and her growing impact as a respected figure in regulatory and biomedical research.

Publication Top Notes

  • Title: Nonclinical Human Cardiac New Approach Methodologies (NAMs) Predict Vanoxerine-Induced Proarrhythmic Potential
    Authors: M. Iveth Garcia, Bhavya Bhardwaj, Keri Dame, Verena Charwat, Brian A. Siemons, Ishan Goswami, Omnia A. Ismaiel, Sabyasachy Mistry, Tromondae K. Feaster, Kevin E. Healy, et al.
    Year: 2025

  • Title: In Vitro Assay Development to Study Pulse Field Ablation Outcome Using Solanum Tuberosum
    Authors: Akshay Narkar, Abouzar Kaboudian, Yasaman Ardeshirpour, Maura Casciola, Tromondae Feaster, Ksenia Blinova
    Year: 2024
    Citations: 2

  • Title: Nonclinical evaluation of chronic cardiac contractility modulation on 3D human engineered cardiac tissues
    Authors: Tromondae K. Feaster, Jourdan K. Ewoldt, Anna Avila, Maura Casciola, Akshay Narkar, Christopher S. Chen, Ksenia Blinova
    Year: 2024

  • Title: Comprehensive Collection of Current Methods for Contractility and Electrophysiology Recordings in Human Cardiac Cells
    Authors: Ksenia Blinova, J. Pierson, A. Narkar
    Year: 2023

  • Title: Human in vitro assay for irreversible electroporation cardiac ablation
    Authors: Maura Casciola, Tromondae K. Feaster, M. J. Caiola, D. Keck, Ksenia Blinova
    Year: 2023

  • Title: Acute effects of cardiac contractility modulation stimulation in conventional 2D and 3D human induced pluripotent stem cell-derived cardiomyocyte models
    Authors: Tromondae K. Feaster, N. Feric, I. Pallotta, A. Narkar, M. Casciola, M. P. Graziano, R. Aschar-Sobbi, Ksenia Blinova
    Year: 2022

  • Title: Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
    Authors: Tromondae K. Feaster, Maura Casciola, Akshay Narkar, Ksenia Blinova
    Year: 2022

  • Title: Human in vitro neurocardiac coculture (iv NCC) assay development for evaluating cardiac contractility modulation
    Authors: Akshay Narkar, Tromondae K. Feaster, Maura Casciola, Ksenia Blinova
    Year: 2022

  • Title: Human cardiomyocytes are more susceptible to irreversible electroporation by pulsed electric field than human esophageal cells
    Authors: Maura Casciola, Devin Keck, Tromondae K. Feaster, Ksenia Blinova
    Year: 2022

  • Title: Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs)
    Authors: Akshay Narkar, James M. Willard, Ksenia Blinova
    Year: 2022

  • Title: Cardiovascular medical devices: Regulatory science research overview in the office of science and engineering laboratories (OSEL) at the food and drug administration (FDA)
    Authors: K. Aycock, Ksenia Blinova, M. Casciola, B. Craven, M. Di Prima, G. D’Souza, N. Duraiswamy, M. Farahmand, P. Hariharan, L. Herbertson, et al.
    Year: 2021

  • Title: Acute effects of cardiac contractility modulation on human induced pluripotent stem cell–derived cardiomyocytes
    Authors: Tromondae K. Feaster, Maura Casciola, Akshay Narkar, Ksenia Blinova
    Year: 2021

Conclusion

Dr. Ksenia Blinova has demonstrated exceptional expertise and leadership in translational and regulatory science, particularly in the evaluation and development of cardiac therapies and medical devices. Her extensive body of research, including numerous high-impact publications on human in vitro cardiac models, contractility modulation, and electroporation assays, reflects a consistent focus on innovative approaches that bridge fundamental science with practical clinical and regulatory applications. She has led multidisciplinary teams to develop tools and methodologies that enhance patient safety, accelerate medical innovation, and provide reliable scientific evidence for regulatory decisions. Her work not only advances the understanding of cardiac electrophysiology and device performance but also sets new standards for predictive, nonclinical cardiac research. Overall, Dr. Blinova’s contributions exemplify the qualities of a pioneering researcher whose scientific rigor, leadership, and commitment to public health make her highly deserving of recognition in any Best Researcher Award.

Lichun Zhao | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Prof. Dr. Lichun Zhao | Pharmacology | Best Researcher Award

Guizhou University of Traditional Chinese Medicine, China

Prof. Dr. Lichun Zhao is a distinguished researcher and academic leader specializing in trace elements, traditional medicine, and health development. He serves as a doctoral supervisor, director of research centers and laboratories, and executive editor in chief of Trace Elements and Health Research, while holding key leadership roles in national and regional scientific associations. Recognized with numerous prestigious honors, he has successfully led major national and international projects, secured innovative medicine approvals, and contributed to product development. His prolific output includes over two hundred publications, highly cited SCI papers, multiple monographs, patents, and software copyrights, reflecting both scientific innovation and practical application. He has also been honored with multiple science and technology awards, underscoring the impact of his research. Committed to advancing both scholarship and healthcare, Prof. Zhao exemplifies excellence in integrating academic research, innovation, and leadership, making him a highly influential figure in his field.

Professional Profile 

Scopus Profile

Education

Prof. Dr. Lichun Zhao earned his Ph.D. in a field closely related to trace elements, medicine, and health sciences, building a solid academic foundation for his future research. Following his doctoral studies, he pursued postdoctoral training at Hong Kong Baptist University, where he broadened his expertise and gained valuable international research exposure. His educational journey reflects a strong emphasis on both traditional medicine and modern scientific approaches, allowing him to bridge classical knowledge with contemporary methodologies. By combining advanced laboratory techniques with deep understanding of traditional Chinese medicine, he has cultivated a unique academic profile that continues to drive his research innovations. His educational background not only prepared him for his roles in academia and research but also established his credentials as a mentor for doctoral students and an authoritative voice in integrating traditional practices with modern scientific frameworks.

Experience

Prof. Dr. Zhao has accumulated extensive academic and professional experience through his multiple leadership roles and active engagement in research. He serves as a doctoral supervisor, guiding and mentoring the next generation of researchers, while simultaneously holding positions as director of the Research Department and the Center for Trace Elements and Health Development at Guizhou University of Chinese Medicine. Beyond his university roles, he directs major laboratories in Guizhou and Guangxi, leading innovation in endangered medicinal resources. His editorial work as executive editor in chief of Trace Elements and Health Research further demonstrates his commitment to advancing scholarly communication. In addition, he actively contributes to national scientific development as a project evaluation expert for significant research foundations and technology awards. Through these experiences, Prof. Zhao has built a career that integrates research, leadership, and service, positioning him as both a pioneering scientist and an influential academic administrator.

Research Focus

The core of Prof. Dr. Zhao’s research lies in the intersection of trace elements, traditional Chinese medicine, and health development. His work emphasizes the exploration of medicinal resources, the development of innovative treatments, and the application of modern scientific tools such as big data and artificial intelligence to healthcare research. He has led numerous national and international projects aimed at advancing understanding of trace elements in human health, as well as developing standardized, evidence-based approaches to traditional medicine. A significant part of his focus is dedicated to the preservation and innovation of endangered medicinal materials, ensuring sustainable resources for future therapeutic use. His achievements include obtaining clinical approvals for new medicine, producing certified products, and publishing influential studies recognized globally. Prof. Zhao’s research is notable for its ability to combine ancient knowledge with modern technology, creating novel solutions that enhance healthcare outcomes and scientific advancement.

Award and Honor

Prof. Dr. Zhao has been widely recognized for his scientific excellence and leadership with numerous national and regional awards. He was the first to receive the prestigious National Youth Qihuang Scholar distinction and has been selected for Hong Kong’s “Excellent Talent Plan.” His honors include recognition as an Outstanding Scholar in Guangxi, a leader of high-level innovation teams, and a candidate in talent development initiatives such as the “Ten Hundred Thousand Talents Project.” He has also received the Guangxi Youth Science and Technology Award and multiple provincial science and technology prizes, including the Guangxi Science and Technology Progress Award and the Jilin Province Natural Science Award. His contributions have further been acknowledged through the China Industry-University-Research Cooperation Innovation Award. Collectively, these distinctions highlight not only his research excellence but also his role as an innovator and leader whose work has had profound impact in both academic and applied scientific fields.

Publications Top Notes

  • Title: The close relationship between trace elements (Cu, Fe, Zn, Se, Rb, Si, Cr, and V) and Alzheimer’s disease: Research progress and insights
    Authors: Zhao Lichun et al.
    Year: 2025

  • Title: Bacteriostatic activity and mechanism of minerals containing rubidium
    Authors: Zhao Lichun et al.
    Year: 2025

  • Title: Traditional Chinese medicine in chronic rhinosinusitis: Mechanisms and postoperative recovery
    Authors: Zhao Lichun et al.
    Year: 2025
    Citations: 3

  • Title: Rosmarinic acid promotes mitochondrial fission and induces ferroptosis in triple-negative breast cancer cells
    Authors: Zhao Lichun et al.
    Year: 2025
    Citations: 13

  • Title: Interfacial Stabilization through MOF-Polymer Core-Shell Design: Ultraefficient, Stable and Recyclable Enzymatic Microreactors
    Authors: Zhao Lichun et al.
    Year: 2025

  • Title: Rubidium salt can effectively relieve the symptoms of DSS-induced ulcerative colitis
    Authors: Zhao Lichun et al.
    Year: 2024
    Citations: 22

Conclusion

The reviewed publications of Prof. Dr. Lichun Zhao reflect a strong and diverse research portfolio spanning trace elements, traditional Chinese medicine, cancer biology, inflammatory diseases, and innovative material science applications. His works demonstrate both depth in exploring mechanisms of disease and breadth in applying interdisciplinary approaches to health solutions. The range of topics covered—from Alzheimer’s disease and rhinosinusitis to breast cancer and ulcerative colitis—highlights his ability to integrate traditional medicine knowledge with modern biomedical and technological advances. The citations already received for some of these recent studies, particularly in high-impact areas such as cancer research and therapeutic innovations, indicate growing recognition of his contributions within the scientific community. Overall, his research achievements showcase academic rigor, innovation, and practical significance, further strengthening his candidacy for recognition through prestigious research awards.

Franciska Erdő | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Prof. Dr. Franciska Erdő | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

full professor at Pázmány Péter Catholic University, Hungary

Franciska Vidáné Dr. Erdő is a distinguished researcher and professor in drug research and development, with extensive experience in academia and the pharmaceutical industry. Born on May 28, 1964, in Budapest, Hungary, she has contributed significantly to pharmacology, drug delivery, and biomedical research. Over her career, she has held leadership roles in prestigious institutions across Hungary, Germany, and France. As a full professor and lab head at Pázmány Péter Catholic University, she plays a key role in advancing scientific knowledge. Her research has been widely recognized, earning her multiple fellowships and memberships in international scientific societies. Dr. Erdő has supervised numerous students, organized international scientific meetings, and served as a reviewer for high-impact journals. She is also actively involved in grant evaluation for major research funding agencies in Europe, further establishing her as a leading expert in her field.

Professional Profile

Education

Dr. Erdő’s academic journey is rooted in pharmaceutical sciences. She obtained her MSc in Pharmacy from Semmelweis University, Faculty of Pharmacy, in 1987 with excellent distinction. She continued her studies at the same institution, earning her University Doctor title in pharmacology in 1994, followed by a PhD in 1997, both summa cum laude. To further enhance her expertise, she pursued a habilitation at Pázmány Péter Catholic University in 2019, ultimately achieving the title of full professor in 2024. Additionally, she has undertaken specialized training, including EU grant writing and experimental animal research under new EU regulations. Her diverse educational background has enabled her to excel in drug development, pharmacology, and biotechnology, equipping her with a strong foundation to lead innovative research in these fields.

Professional Experience

Dr. Erdő’s professional career spans more than three decades, encompassing roles in academia, research institutes, and the pharmaceutical industry. She has held various research fellow and senior research fellow positions in leading institutions such as Sanofi-Synthelabo Chinoin, IVAX Drug Research Institute, and SOLVO Biotechnology. Between 2000 and 2003, she was a Max Planck Fellow at the Max-Planck Institute in Germany, furthering her expertise in neurological research. She has also worked as a scientific researcher at Charité Medical University in Berlin. Since 2014, she has been an integral part of Pázmány Péter Catholic University, where she has progressed from senior research fellow to full professor and lab head. Her leadership in drug research and development, coupled with her extensive collaborations with international institutions, has significantly contributed to the advancement of pharmaceutical sciences.

Research Interests

Dr. Erdő’s research focuses on drug delivery across physiological barriers, including the skin, blood-brain barrier, and mucosal tissues. Her studies explore transdermal and intranasal drug administration, pharmacokinetics, and tissue engineering. She has contributed to the development of lab-on-a-chip models for drug testing, providing innovative solutions for pharmaceutical research. Her interdisciplinary approach combines pharmacology, biomedical engineering, and nanotechnology to improve drug formulation and delivery methods. She has authored numerous high-impact publications on skin permeability, microfluidic diffusion chambers, and age-related changes in drug absorption. Her research also includes in vitro and ex vivo studies on skin-on-a-chip platforms, contributing to advancements in personalized medicine. Dr. Erdő’s work has gained international recognition, shaping the future of drug development and targeted therapy solutions.

Awards and Honors

Dr. Erdő has been the recipient of numerous prestigious awards and fellowships throughout her career. She was a Max Planck Fellow from 2000 to 2003, a Charité Medical University Scholar in 2006, and a recipient of the LE STUDIUM Fellowship in 2022 under the Smart Loire Valley program in France. Her excellence in teaching and research has been recognized through multiple Teaching-Research Excellence Scholarships at Pázmány Péter Catholic University. She has also received publication fellowships for her outstanding contributions to scientific literature. Additionally, she plays a crucial role as a grant evaluator for the EU’s Horizon programs, the Austrian Science Fund, and other major research funding agencies. Her achievements highlight her significant impact on the global scientific community, reinforcing her reputation as a leading expert in pharmaceutical and biomedical research.

Conclusion

Dr. Franciska Vidáné Erdő is a highly suitable candidate for the Best Researcher Award due to her outstanding contributions to drug research, mentorship, and international collaborations. Her extensive publication record, leadership in scientific organizations, and impact on pharmacology and biomedical sciences make her a strong contender. Enhancing industry engagement and public science communication could further solidify her position as a top researcher.

Publications Top Noted

1. In Vitro Functional and Structural Evaluation of Low-Complexity Artificial Human Epidermis for 3D Tissue Engineering

  • Author: Erdő F., et al.
  • Year: 2025
  • Journal: Bioengineering
  • DOI: 10.3390/bioengineering12030230

2. Fluid Dynamics Optimization of Microfluidic Diffusion Systems for Assessment of Transdermal Drug Delivery: An Experimental and Simulation Study

3. Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations

4. Mathematical Modeling of Transdermal Delivery of Topical Drug Formulations in a Dynamic Microfluidic Diffusion Chamber in Health and Disease

5. Rodent Models of Dermatological Disorders

6. Models for Barrier Understanding in Health and Disease in Lab-on-a-Chips

7. Transdermal Delivery of α-Aminophosphonates as Semisolid Formulations—An In Vitro-Ex Vivo Study

8. Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)-In Vitro Testing

9. Editorial: Women in Drug Metabolism and Transport: 2021

10. Structural and Functional Analysis of Excised Skins and Human Reconstructed Epidermis with Confocal Raman Spectroscopy and in Microfluidic Diffusion Chambers

11. Novel Aspects of Raman Spectroscopy in Skin Research

  • Author: Erdő F., et al.
  • Year: 2022
  • Journal: Experimental Dermatology
  • DOI: 10.1111/exd.14645

12. Characterization and Ex Vivo Evaluation of Excised Skin Samples as Substitutes for Human Dermal Barrier in Pharmaceutical and Dermatological Studies

  • Author: Erdő F., et al.
  • Year: 2022
  • Journal: Skin Research and Technology
  • DOI: 10.1111/srt.13165

13. Drug Delivery through the Psoriatic Epidermal Barrier—A “Skin-On-A-Chip” Permeability Study and Ex Vivo Optical Imaging

  • Author: Erdő F., et al.
  • Year: 2022
  • Journal: International Journal of Molecular Sciences
  • DOI: 10.3390/ijms23084237

14. Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments

15. Age-Related Inflammatory Balance Shift, Nasal Barrier Function, and Cerebro-Morphological Status in Healthy and Diseased Rodents

 

Dr. Anca-Roxana Petrovici | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Dr. Anca-Roxana Petrovici | Pharmacology | Best Researcher Award

Dr. Anca-Roxana Petrovici, “Petru Poni” Institute of Macromolecular Chemistry, Romania

Dr. Anca-Roxana Petrovici is a prominent researcher at the “Petru Poni” Institute of Macromolecular Chemistry in Romania. With a strong focus on macromolecular science, she has made significant contributions to the field through her innovative research and publications, aiming to advance knowledge and applications in polymer chemistry.

Profile

Scopus

Orcid

Education 🎓

Dr. Petrovici obtained her Ph.D. in Macromolecular Chemistry, where her thesis focused on the synthesis and characterization of novel polymer materials. Her academic journey has been marked by a commitment to excellence and a passion for advancing the field of polymer science.

Experience 💼

With extensive experience at the “Petru Poni” Institute, Dr. Petrovici has engaged in various research projects and collaborations, contributing to the development of new materials and applications. Her role has also involved mentoring students and collaborating with industry partners to apply scientific findings practically.

Research Interest 🔬

Dr. Petrovici’s research interests lie primarily in the synthesis, characterization, and application of macromolecular materials. She focuses on the development of innovative polymers with specific functionalities, exploring their potential in diverse fields such as biomedicine, packaging, and nanotechnology.

Awards 🏆

Throughout her career, Dr. Petrovici has received numerous accolades recognizing her contributions to polymer chemistry. While specific awards are not listed here, her work has been widely cited, reflecting her influence in the scientific community.

Publication Top notes 📚

Correction: Simionescu et al. The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene Therapy. Pharmaceutics 2021, 13, 988

Phenolic Composition and Bioactivities of Invasive Ailanthus altissima (Mill.) Swingle Leaf Extracts Obtained by Two-Step Sequential Extraction

In Vitro Screening of Ecotoxic and Cytotoxic Activities of Ailanthus altissima Leaf Extract against Target and Non-Target Plant and Animal Cells

Enhancing the Antioxidant Potential of Weissella confusa PP29 Probiotic Media through Incorporation of Hibiscus sabdariffa L. Anthocyanin Extract

Complexes of Ibuprofen Thiazolidin-4-One Derivatives with β-Cyclodextrin: Characterization and In Vivo Release Profile and Biological Evaluation

NEW METAL COMPLEXES WITH ARIL-ACETIC STRUCTURE: PREPARATION, CHARACTERIZATION, AND IN VITRO ANTIINFLAMMATORY EFFECTS

Dextran-Chitosan Composites: Antioxidant and Anti-Inflammatory Properties

3D Matrices for Enhanced Encapsulation and Controlled Release of Anti-Inflammatory Bioactive Compounds in Wound Healing

Dextran Formulations as Effective Delivery Systems of Therapeutic Agents

Probiotic Properties of Weissella confusa PP29 on Hibiscus sabdariffa L. Media

Rosa María Martínez-Espinosa | Biochemistry | Best Researcher Award

Published on by World Top Scientists

Prof Dr. Rosa María Martínez-Espinosa | Biochemistry | Best Researcher Award

Prof, University of Alicante, Spain

Dr. Rosa María Martínez-Espinosa, born in Alicante, Spain, is a distinguished biochemist and full professor at the University of Alicante. She leads the Applied Biochemistry Research Group and is well-known for her extensive research on extremophiles and their industrial applications. Dr. Martínez-Espinosa has made significant contributions to biotechnology, with over 100 publications in indexed journals, more than 200 conference presentations, and 70 book chapters. She also serves as the Vice President for International Relations and Development Cooperation at the University of Alicante. 🌍🔬

Publication Profile

ORCID

Education

Dr. Martínez-Espinosa earned her PhD in Biology from the University of Alicante in 2003, where she was awarded the Extraordinary Doctorate Award. She previously completed her BSc (Hons) in Biology at the same institution in 1998. 🎓📚

Experience

Dr. Martínez-Espinosa has held various academic positions at the University of Alicante since 2001. She began as an associate professor, advancing to senior lecturer and eventually full professor in 2020. Alongside her teaching, she has served in multiple leadership roles, including Vice-Dean for Postgraduate Programs and Vice-President for International Relations. She has also conducted research at the University of East Anglia, UK, during multiple research visits. 💼🏫

Research Focus

Her research focuses on the metabolism of extremophiles, biotechnological applications of microorganisms, enzyme purification, genetic manipulation of microorganisms, carotenoid production, and environmental bioremediation. Her work is funded by European and national grants, contributing to advances in microbial biotechnology and bioengineering. 🔬🧪

Awards and Honours

Dr. Martínez-Espinosa has been recognized with numerous accolades, including the 2024 Sprint-Valoriza Award for her project on Microbial Biotechnology, multiple Top Reviewer Awards by Web of Science in Biochemistry, Genetics, and Molecular Biology, and the 2013 Excellence in Teaching Award from the University of Alicante. 🏆🎖️

Publication Top Notes

Halocins and C<sub>50</sub> Carotenoids from Haloarchaea: Potential Natural Tools against Cancer

Production of Poly(3-hydroxybutyrate-<i>co</i>-3-hydroxyvalerate) (PHBV) by <i>Haloferax mediterranei</i> Using Candy Industry Waste as Raw Materials

Controversy over the Use of “Shade Covers” to Avoid Water Evaporation in Water Reservoirs

 

Samer Younes | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Dr. Samer Younes | Pharmacology | Best Researcher Award

Department of Pharmacy, Tartous University, Syria

🌟 Samer Younes is a dedicated and forward-thinking pharmacy graduate from Tartous University, Syria. With a strong academic background and diverse experience in both practical pharmacy and research, Samer is committed to continuous learning and professional development. His work ethic is demonstrated through his active participation in community volunteering, internships, and a keen interest in expanding his expertise in the field of pharmacy and nutrition.

Profile

Google Scholar

Research for “Best Researcher Award”

Strengths for the Award

1. Strong Academic Foundation and Practical Experience:
Samer Younes has demonstrated a solid academic foundation with a Bachelor’s degree in Pharmacy from Tartous University, complemented by practical experience in various pharmacy roles and internships. His work as a pharmacist involved crucial tasks such as prescription processing and handling patient queries, showcasing his applied knowledge in the field.

2. Commitment to Continuous Learning and Professional Development:
Samer’s commitment to professional growth is evident from his various certifications, including Quality Advisor and specialized training in Nutrition and Laboratory Work. These certifications not only add to his qualifications but also highlight his proactive approach to expanding his skill set and knowledge.

3. Volunteer Experience and Community Engagement:
His volunteer work with UNICEF and involvement in the Campaign against Covid-19 underline his dedication to societal well-being and public health. His role in these initiatives, including vaccinations and monitoring children’s rights, demonstrates his ability to apply his expertise in real-world scenarios and contribute to community health.

4. Language and Digital Skills:
Samer possesses proficiency in multiple languages, which enhances his ability to communicate and collaborate in diverse settings. His digital skills, including expertise in Microsoft Office and analytical tools, are essential for modern research and data analysis.

5. Strong Recommendations:
Samer has received commendations from reputable professors, such as Wissam Zam and Zeina Hamama, who can vouch for his academic prowess and research capabilities. Their recommendations add credibility to his achievements and potential as a researcher.

Areas for Improvement

1. Limited Research Publications:
While Samer has a commendable academic background and practical experience, his publication record appears limited. Expanding his research output and publishing in high-impact journals could enhance his visibility and influence in the field of pharmacy and research.

2. Focused Research Experience:
Although Samer has engaged in diverse roles and projects, a more focused research experience in specific areas of pharmacy or a related field could strengthen his application. Specializing in a niche area and contributing significant research could further solidify his candidacy for the award.

3. Networking and Collaboration:
Building a stronger professional network and engaging in collaborative research projects could provide additional opportunities for growth and recognition. Participating in conferences and research forums would also help him gain further exposure and feedback from the scientific community.

4. Enhanced Research Visibility:
Increasing his presence in research communities, such as ResearchGate and Google Scholar, by regularly updating his profiles and engaging with other researchers could improve his visibility and impact in the research domain.

Education

🎓 Bachelor Degree in Pharmacy
Department of Pharmacy, Tartous University
(01/09/2018 – 31/01/2024)
Samer graduated with a final grade of 72.2/100, having gained a solid foundation in pharmaceutical sciences and practical experience through his coursework and projects.

Experience

💊 Pharmacist
Ghadeer Pharmacy
(01/12/2020 – 19/08/2022)
Samer managed prescription processing, handled patient queries, ensured compliance with pharmacy regulations, and updated inventory information, showcasing his practical expertise in the pharmaceutical field.

🔬 Internship: Campaign Against Covid-19
(12/09/2020 – 12/05/2021)
In this role, Samer contributed to examinations and vaccinations, playing a crucial part in the fight against the pandemic.

🌍 Volunteering: UNICEF
(18/11/2013 – 20/11/2013)
Samer’s work with UNICEF included training and voluntary activities, reflecting his commitment to global health and community support.

Research Interests

Samer’s research interests lie in the intersection of nutrition and pharmacology, particularly focusing on the impact of micronutrients on health conditions and treatment outcomes. His work aims to advance understanding in these areas and contribute to more effective therapeutic strategies.

Awards and Certifications

  • Quality Advisor – Insight (Training Development & Consulting) (24/11/2022 – 28/11/2022)
  • Laboratory Work Level 1+2 – Insight (24/11/2022 – 28/11/2022)
  • Nutrition and Diets – Insight (02/02/2022 – 20/02/2022)
  • Nutrition Basics – Insight (12/12/2021 – 20/12/2021)

Publications Top Notes

  1. The Role of Nutrition on the Treatment of Covid-19
    Human Nutrition & Metabolism, 200255 (2024)
    Cited by: 4
  2. The Role of Micronutrients on the Treatment of Diabetes
    Human Nutrition & Metabolism, 200238 (2024)
    Cited by: 4
  3. The Impact of Micronutrients on the Sense of Taste
    Human Nutrition & Metabolism, 200231 (2023)
    Cited by: 2
  4. The Relationship Between Gender and Pharmacology
    Current Research in Pharmacology and Drug Discovery, 100192 (2024)
    Cited by: 1

Conclusion

Samer Younes exhibits many strengths that align well with the criteria for the “Best Researcher Award.” His academic qualifications, practical experience, and dedication to continuous learning and community service are commendable. To strengthen his candidacy, focusing on increasing his research publications, specializing in a specific area, and enhancing his professional network and visibility will be crucial. With his solid foundation and commitment to growth, Samer has the potential to make significant contributions to the field and be a strong contender for the award.